单独的BRD4-NUT融合驱动了NUT癌的恶性转变
R Taylor Durall1, Julianna Huang1, Luke Wojenski2
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
开发了一种新的NUT癌 (NC) 的基因工程小鼠模型 (GEMM). 这种由BRD4-NUT融合驱动的模型模拟了人类NC,并显示了临床前研究和改善这种侵袭性癌症的治疗策略的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 核突瘤 (NC) 是一种具有攻击性的平细胞癌,其特征是BRD4-NUT融合瘤蛋白.
- 目前对NC的全身治疗方法通常是无效的,缺乏足够的动物模型阻碍了治疗的发展.
- 了解细胞外部因素和开发有效的NC治疗方法仍然是一个重大挑战.
研究的目的:
- 创建一个基因工程鼠标模型 (GEMM) 的NUT癌症 (NC) 准确地复制人类疾病特征.
- 利用该模型研究NC驱动机制和治疗干预措施的临床前测试.
- 为研究这个侵略性,经常致命的癌症的研究社区建立一个有价值的资源.
主要方法:
- 在Sox2驱动的Cre表达小鼠中诱导Brd4::NUTM1融合基因,开发NC的GEMM.
- 在GEMM中瘤形成,组织学,基因表达 (转录学) 和表观遗传景观的表征.
- 建立和分析GEMM衍生细胞系.
- 评估小分子BET代胺抑制 (BETi) 的治疗疗效.
主要成果:
- 该NC GEMM表现出完整的疾病透性,瘤来自状上皮层,导致死亡.
- GEMM瘤 (mNC) 与人类NC (hNC) 非常相似,表现出差异化,高MYC表达和转移.
- 来自GEMM的细胞系反映了初级GEMM瘤和人类NC的转录和表观遗传特征.
- 在NC GEMM中,BET抑制诱导了差异化,生长停止和延长生存时间,类似于hNC模型.
- 这项研究证实BRD4-NUT是状原生细胞恶性转变的强有力的驱动因素.
结论:
- 开发的NC GEMM作为人类NUT癌症的强大而准确的临床前模型.
- 该模型总结了人类NC的关键特征,包括其侵略性和对BET抑制的反应.
- 这些发现验证了BRD4-NUT作为主要的瘤驱动因素,并突出了BET抑制剂对NC的治疗潜力.
- 免疫能力强的GEMM为未来的NC机制和治疗研究提供了至关重要的资源.
更多相关视频
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
